Cell & Bioscience volume 12, Article number: 201 (2022)
The Original Article was published on 14 October 2022
In this article [1], during proof correction process, the correction in Figure 4c was incorrectly updated. The correct version of Figure 4c should have appeared as shown in this correction.
Zhu Q, Qin M, Wang Z, Yonglin Wu, Chen X, Liu C, Ma Q, Liu Y, Lai W, Chen H, Cai J, Liu Y, Lei F, Zhang B, Zhang S, He G, Li H, Zhang M, Zheng H, Chen J, Huang M, Zhong S. Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease. Cell Biosci. 2022;12:173. https://doi.org/10.1186/s13578-022-00863-x.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Zhu, Q., Qin, M., Wang, Z. et al. Correction: Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease. Cell Biosci 12, 201 (2022). https://doi.org/10.1186/s13578-022-00926-z
Accepted:
Published:
DOI: https://doi.org/10.1186/s13578-022-00926-z
